A 62-year-old with type 2 diabetes is on maximum metformin therapy but still has an HbA1c above target. He is obese (BMI 36 kg/m2). According to NICE ...

Question

A 62-year-old with type 2 diabetes is on maximum metformin therapy but still has an HbA1c above target. He is obese (BMI 36 kg/m2). According to NICE guidelines, which class of medication could be added to promote weight loss and glycaemic control?

Accepted Answer

GLP-1 receptor agonist (e.g. liraglutide)

Answer

Sulfonylurea (e.g. gliclazide)

Answer

Basal insulin

Answer

Thiazolidinedione (e.g. pioglitazone)

Answer

DPP-4 inhibitor (e.g. sitagliptin)

ukmla MCQ (SBA): Type 2 Diabetes

A 62-year-old with type 2 diabetes is on maximum metformin therapy but still has an HbA1c above target. He is obese (BMI 36 kg/m2). According to NICE guidelines, which class of medication could be added to promote weight loss and glycaemic control?